WASHINGTON, Feb. 4, 2025 /PRNewswire/ -- Inflectra, a global leader in software lifecycle management solutions, announced today that it has joined the Amazon Web Services (AWS) Independent Software ...
The KSA Region will enable Inflectra to run workloads and securely store content in Saudi Arabia while serving end users with even lower latency. By hosting Inflectra's platforms on the local AWS KSA ...
Inflectra, a leading maker of IT software lifecycle management solutions, today announced its latest Spira platform version release. The company’s Spira Version 7.0, which includes SpiraTest, ...
WASHINGTON, May 13, 2025 /PRNewswire/ -- Inflectra, a global leader in software lifecycle management and test automation solutions, today announced the general availability of Inflectra.ai, its ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Researchers have observed a “modest uptake” in the use of biosimilars for infliximab in the past 18 ...
The U.S. Food and Drug Administration announced on April 5 its second ever approval of a biosimilar – Inflectra (infliximab-dyyb) – for multiple indications. Inflectra was developed by Celltrion Inc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results